Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuji Kumagai

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|March 25, 2004
Strategies against high blood pressure in the early morningYuji Kumagai
Clinical Calcium|October 26, 2016
[Pharmacokinetics of anti-RANKL antibody drugs:Denosumab.]Rieko Tanaka, Yuji Kumagai
Journal of Pharmacokinetics and Pharmacodynamics|May 12, 2021
Concentration-QTc analysis with two or more correlated baselinesYasushi Orihashi, Yuji Kumagai
Bone|August 30, 2011
A randomized, double-blind, placebo-controlled, single-dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of denosumab administered subcutaneously to postmenopausal Japanese womenYuji Kumagai, Tomoko Hasunuma, Desmond Padhi
Clinical Pharmacology in Drug Development|February 22, 2022
Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Isavuconazonium Sulfate in Healthy Adult Japanese SubjectsShinichiro Shirae, Atsushi Ose, Yuji Kumagai
Pharmaceutical Statistics|December 9, 2020
Novel concentration-QTc models for early clinical studies with parallel placebo controls: A simulation studyYasushi Orihashi, Yuji Kumagai, Kazuhito Shiosakai
Journal of Pharmacokinetics and Pharmacodynamics|January 29, 2021
Concentration-QTc analysis for single arm studiesYasushi Orihashi, Shoichi Ohwada, Yuji Kumagai
Clinical and Translational Science|May 25, 2026
Effects of Nacubactam and Its Metabolites on QTc Interval: A Pooled Analysis of Two Randomized Phase 1 StudiesJun Morita, Sue McKendrick, Yuji Kumagai
Clinical and Experimental Nephrology|February 21, 2020
A drug-drug interaction study of a novel, selective urate reabsorption inhibitor dotinurad and the non-steroidal anti-inflammatory drug oxaprozin in healthy adult malesKenichi Furihata, Katsuaki Nagasawa, Atsushi Hagino, et al.
Journal of Clinical Pharmacology|July 14, 2017
Dosage Optimization of Nemolizumab Using Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Modeling and SimulationTomohisa Saito, Satofumi Iida, Kimio Terao, et al.
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|March 25, 2004
Strategies against high blood pressure in the early morningYuji Kumagai
Clinical Calcium|October 26, 2016
[Pharmacokinetics of anti-RANKL antibody drugs:Denosumab.]Rieko Tanaka, Yuji Kumagai
Journal of Pharmacokinetics and Pharmacodynamics|May 12, 2021
Concentration-QTc analysis with two or more correlated baselinesYasushi Orihashi, Yuji Kumagai
Bone|August 30, 2011
A randomized, double-blind, placebo-controlled, single-dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of denosumab administered subcutaneously to postmenopausal Japanese womenYuji Kumagai, Tomoko Hasunuma, Desmond Padhi
Clinical Pharmacology in Drug Development|February 22, 2022
Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Isavuconazonium Sulfate in Healthy Adult Japanese SubjectsShinichiro Shirae, Atsushi Ose, Yuji Kumagai
Pharmaceutical Statistics|December 9, 2020
Novel concentration-QTc models for early clinical studies with parallel placebo controls: A simulation studyYasushi Orihashi, Yuji Kumagai, Kazuhito Shiosakai
Journal of Pharmacokinetics and Pharmacodynamics|January 29, 2021
Concentration-QTc analysis for single arm studiesYasushi Orihashi, Shoichi Ohwada, Yuji Kumagai
Clinical and Translational Science|May 25, 2026
Effects of Nacubactam and Its Metabolites on QTc Interval: A Pooled Analysis of Two Randomized Phase 1 StudiesJun Morita, Sue McKendrick, Yuji Kumagai
Clinical and Experimental Nephrology|February 21, 2020
A drug-drug interaction study of a novel, selective urate reabsorption inhibitor dotinurad and the non-steroidal anti-inflammatory drug oxaprozin in healthy adult malesKenichi Furihata, Katsuaki Nagasawa, Atsushi Hagino, et al.
Journal of Clinical Pharmacology|July 14, 2017
Dosage Optimization of Nemolizumab Using Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Modeling and SimulationTomohisa Saito, Satofumi Iida, Kimio Terao, et al.
Pageof 10